Please Wait...

Classic Blog

Stronger Through Collaboration: A new wave of eHealth Solutions

  • 0
  • 15 Aug

Learning about new technologies and thinking strategically about their application in life sciences to ultimately benefit patients is what motivates me. This makes my role at Bioclinica a perfect fit as I get to partner with developers of innovative patient-centered applications from around the world for our eHealth App xChange.

Read More

Bioclinica's Research Network Goes Global with Compass Acquisition

  • 0
  • 12 Aug

Bioclinica's extensive Research Network of full-service clinical study sites – already located in Asia, Europe, and Latin America – achieved a global status with the recent acquisition of Compass Research. As reviewed in the CenterWatch Weekly publication, the acquisition will expand Bioclinica's Research Network into the U.S., providing a true global site network for pharmaceutical companies engaged in clinical research.

Read More

How Do You Get People to Join Clinical Trials? Show a Movie!

  • 0
  • 10 Aug

Many people don't understand what a clinical trial is or how one is conducted. This can make it hard to recruit and screen the hundreds and often thousands of patients necessary to find qualified individuals to participate in a given study.

Read More

End-to-End Patient Engagement Is a Reality

  • 0
  • 09 Aug

Patient engagement is an ongoing challenge when conducting clinical trials. A recent article published in CenterWatch Weekly noted, "Experts point to problems with awareness, understanding, and trust among potential trial participants as well as providers that persists today. They also cite the disconnect between a patient's interest in participating in a trial and actually taking the next step to enroll.

Read More

Clinical Trial Forecasting: Managing the Challenges and Avoiding the Fines

  • 0
  • 08 Aug

Last week, Jim Sacchetta, Manager, Technical Operations, Premier Research, and I hosted a webinar titled "Clinical Trial Forecasting: Managing the Challenges and Avoiding the Fines." During the webinar, we took an in-depth look at:

Read More

Explosive Growth in Post-Approval Research Drives Increased Cost and Complexity

  • 0
  • 04 Aug

In the 1970s, post-approval studies were rarely performed. The 1980s saw a slight rise when the FDA began to require post-approval research as a condition for the approval of certain drugs. Fast forward to 2014, when a full 13.7% of total R&D costs was spent on conducting post-approval studies. What fueled this explosive growth in post-approval research in such a relatively short period of time? And – critically – what are the ramifications of that growth?

Read More
Finding the Right End-to-End Safety Solution for Your Needs

Finding the Right End-to-End Safety Solution for Your Needs

  • 0
  • 25 Jul

Last week, I hosted a webinar titled, "Finding the Right End-to-End Safety Solution for Your Needs." During the webinar, we took an in-depth look at:

Read More

The Art of the Rescue - Navigating Potential Pitfalls during Imaging Vendor Transition

  • 0
  • 21 Jul

Once considered a rarity within the medical imaging vendor space, the decision by sponsors to transition imaging core lab after startup has become increasingly more common. Due to the complexity of clinical trials, there may come a time where as a Sponsor you will need to transition vendors after study startup. Reasons for this change of service provider can typically involve challenges with the current provider's timelines, quality, resources, or expertise.

Read More

Introducing OnPoint Direct, Bioclinica's Powerful Rapid Startup CTMS

  • 0
  • 19 Jul

With thousands of people, hundreds of investigative sites, multiple CROs and various eClinical source systems—all generating massive amounts of data—clinical trials are an enormous undertaking. While leading organizations use Clinical Trial Management Systems (CTMS) to centralize operational data and automate processes so they can make better decisions, a CTMS can be out of reach for many small to mid-size companies, leaving them with isolated spreadsheets and/or inefficient, manual practices.

Read More

Meet the Bioclinica Financial Lifecycle Solutions Team: Meghan Harrington, Director of Client Delivery

  • 0
  • 14 Jul

At Bioclinica, we are proud to provide our clients with scalable financial lifecycle solutions that can handle global payments as well as integrate with any EDC, CTMS and RTSM. As of April 4, 2016, we've helped Sponsors and CROs make $285 million in payments to 9,012 sites with 70,972 subjects in 63 counties. However, although our technology is a huge factor in our clients' successes, we wouldn't be nearly as successful without the extensive clinical trial expertise that our team members bring to the table.

Read More

What’s Next for the European Economic Area (EEA) Qualified Person for Pharmacovigilance (QPPV) Working in the UK?

  • 0
  • 12 Jul

Last week, on June 23, 2016, the European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA) acknowledged the outcome of the referendum on the United Kingdom's (UK) membership of the European Union (EU).

EMA stated that its implications for the Agency's location and operations depend on the future relationship between the UK and the EU, which is unknown at present.

Read More

CDISC eSource Stakeholders Plan to Supply Pharma with Path Forward for Collection of EHR and Other eSource Data

  • 0
  • 11 Jul

CDISC held an eSource stakeholders meeting on March 18, 2016 during the CDISC interchange in Silver Spring, MD. The initial invitation said "During this initial meeting, we plan to discuss the charter and plans for this group as well as introduce members to each other and update the group on recent work."

Read More

Pages

Reflections on My Experience at the 2017 DIA Pharmacovigilance and Risk Management Strategies Conference

  • 0
  • 22 Feb

Compared with the 2016 Drug Industry Association (DIA) Pharmacovigilance and Risk Management Strategies Conference, the 2017 conference in Washington, D.C. had a much better start. Although I was not at last year's conference, I read the epic testimonials of snowstorms, canceled flights, lockdowns and other interesting events, which were all very entertaining.

This year's DIA Pharmacovigilance and Risk Management Strategies Conference, which I attended, was less eventful, and yet, still full of encounters, lively discussions and as always, laughter.

Read More

Why Your RBM System Should be SMART, Not Pretty

  • 0
  • 09 Feb

There is long-standing recognition that Risk-Based Monitoring (RBM) is essential to ensuring the safety of your patients and the success of your clinical trial. Data quality and patient safety are also at the core of quality by design (QbD) initiatives, which focus on identifying key risks to subject safety, data quality and GCP/regulatory compliance, setting the foundation for RBM implementation.

Read More

How Optimizing Your Supply Chain Management Can Reduce Trial Cost, Effort and Risk

  • 0
  • 07 Feb

Today's Supply Chain
We can all recognize that there is a need to better manage the increasingly uncertain and complex drug supply chain, which is affected by the inclusion of more patients, at more sites and in more countries; country-specific regulations and approvals for temperature-controlled drugs, packaging, labeling and logistics; and more intricate protocols.

Read More

When Designing Clinical Trial Software, Put Your Users First

  • 0
  • 20 Jan

What's the best way to design software that your customers will actually enjoy using?

Ask your users.

It sounds obvious enough, but you would be surprised by how infrequently this perspective is taken into consideration when designing clinical trial software.

Read More

Pages

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @lauren_chazal: Talking about metrics at MAGI East! @bioclinica #magieast2017 #magi17 https://t.co/vfsvbqbMnF
bioclinica (10 hours ago)
We have an incredibly experienced and motivated team focused on accelerating our ability to do what’s... https://t.co/HjjLpn7aAN
bioclinica (12 hours ago)
Industry latest via CenterWatch News Online https://t.co/hgyMUAL1oZ
bioclinica (15 hours ago)
RT @lauren_chazal: Envisioning e-research in 2020 #magi2017 @bioclinica https://t.co/SOvp0Cttia
bioclinica (15 hours ago)
[blog] A primer on #Biomarkers in #ClinicalResearch https://t.co/3rmy3rnKFb
bioclinica (3 days ago)
RT @ACRPDC: Happy #clinicaltrialsday! Join the celebration by telling us what you are doing as a #clinicalresearch professional. https://t.…
bioclinica (3 days ago)

Latest Blogs: